Myopathy and eosinophilic pneumonia coincidentally induced by treatment with daptomycin.

Published on Jan 1, 2015in Internal Medicine1.005
· DOI :10.2169/INTERNALMEDICINE.54.3397
Hideharu Hagiya3
Estimated H-index: 3
(Okayama University),
Kou Hasegawa5
Estimated H-index: 5
(Okayama University)
+ 7 AuthorsFumio Otsuka35
Estimated H-index: 35
(Okayama University)
Sources
Abstract
: A 34-year-old man with 22q11.2 deletion syndrome (DiGeorge syndrome) concurrently suffered from myopathy and eosinophilic pneumonia shortly after receiving daptomycin (DAP) for right-sided infective endocarditis. The simultaneous occurrence of these phenomena in relation to DAP therapy has not been previously well described. An allergic reaction was suspected as a possible etiology of these DAP-related complications. This case highlights the need for close observation in order to detect both musculoskeletal and respiratory disorders from the start of DAP therapy. Physicians should pay more attention to this new drug, which is expected to be frequently used in various clinical settings.
📖 Papers frequently viewed together
12 Citations
20123.44Drug Safety
6 Authors (Peter W. Kim, ..., Sumathi Nambiar)
43 Citations
26 Citations
References32
Newest
#1Anita RajagopalH-Index: 1
#2Edward MintzH-Index: 1
Last. Lindsey ReeseH-Index: 1
view all 3 authors...
4 CitationsSource
#1Marco Falcone (Policlinico Umberto I)H-Index: 37
#2Alessandro Russo (Policlinico Umberto I)H-Index: 9
Last. Manjunath P. Pai (Albany College of Pharmacy and Health Sciences)H-Index: 30
view all 5 authors...
Background. Higher daptomycin doses are advocated for select methicillin-resistant Staphylococcus aureus (MRSA)–related infections, but the probabilities of target attainment (PTA) and toxicity of these doses have not been characterized in critically ill patients. Methods. We evaluated the plasma pharmacokinetics (PK) and clinical outcomes of a cohort of critically ill patients treated with daptomycin 6–8 mg/kg/day for primarily Staphylococcus species–related infections. Daptomycin concentration...
88 CitationsSource
#1Jason Phillips (University of Texas Health Science Center at San Antonio)H-Index: 2
#2Anthony P. Cardile (San Antonio Military Medical Center)H-Index: 6
Last. James S. Lewis (University of Texas Health Science Center at San Antonio)H-Index: 35
view all 4 authors...
AbstractAcute eosinophilic pneumonia (AEP) is a rare but important complication of daptomycin therapy. We describe 2 cases of daptomycin-associated AEP, compile available data from another 22 published cases, and propose a revised set of diagnostic criteria.
18 CitationsSource
#1Chung-Chih Lai (KMU: Kaohsiung Medical University)H-Index: 5
#2Wang-Huei Sheng (NTU: National Taiwan University)H-Index: 46
Last. Shan-Chwen Chang (NTU: National Taiwan University)H-Index: 80
view all 7 authors...
Background Increasing the dosage of daptomycin may be advantageous in severe infection by enhancing bactericidal activity and pharmacodynamics. However, clinical data on using daptomycin at doses above 6 mg/kg in Asian population are limited.
24 CitationsSource
#1Peter W. Kim (FDA: Food and Drug Administration)H-Index: 5
#2Alfred Sorbello (FDA: Food and Drug Administration)H-Index: 3
Last. Sumathi Nambiar (FDA: Food and Drug Administration)H-Index: 8
view all 6 authors...
Background: Eosinophilic pneumonia (EP) has been noted in association with daptomycin use. The product labelling was recently updated to include EP in the Warnings and Precautions and Post-Marketing Experience sections.
43 CitationsSource
#1Claudia Colomba (University of Palermo)H-Index: 25
#2Raffaella Rubino (University of Palermo)H-Index: 8
Last. Lucina Titone (University of Palermo)H-Index: 27
view all 5 authors...
7 CitationsSource
: There is a daunting list of toxins that can affect the peripheral nervous system, with new drugs and chemicals added to this list every year. This article focuses on some of the more recent toxic neuropathies and myopathies that have emerged from the medical literature. Among these are toxic myopathies caused by statins, daptomycin, imatinib, hydroxychloroquine, and highly active antiretroviral therapy; neuromuscular junction toxicity caused by tandutinib; toxic peripheral neuropathies caused ...
8 CitationsSource
#1C. RetherH-Index: 1
#2A. ConenH-Index: 1
Last. W. C. AlbrichH-Index: 1
view all 4 authors...
We report a 69-year-old patient who developed fever and dyspnea 3 weeks after the initiation of daptomycin therapy for spondylodiscitis with lumbar epidural and bilateral psoas abscesses due to ampicillin- and high-level-gentamicin-resistant Enterococcus faecium. There was profound hypoxia and the chest X-ray showed extensive patchy infiltrates bilaterally. A bronchoalveolar lavage revealed 30% eosinophils and results of microbiological studies were normal. Daptomycin-induced eosinophilic pneumo...
11 CitationsSource
#1Ravina Kullar (Eugene Applebaum College of Pharmacy and Health Sciences)H-Index: 22
#2Susan L. Davis (Eugene Applebaum College of Pharmacy and Health Sciences)H-Index: 29
Last. Michael J. Rybak (Eugene Applebaum College of Pharmacy and Health Sciences)H-Index: 89
view all 9 authors...
Study Objective. To evaluate the clinical response and safety of high-dose daptomycin for treatment of complicated gram-positive infections. Design. Multicenter, retrospective, observational, case series analysis. Setting. Five academic medical centers in four major United States cities. Patients. Two hundred fifty adults, not undergoing dialysis, who received high-dose daptomycin (≥ 8 mg/kg/day) for at least 72 hours for complicated gram-positive infections between January 1, 2005, and March 1,...
120 CitationsSource
#1Armando Gonzalez-Ruiz (Valley Hospital)H-Index: 7
Last. Ricardo L. Chaves (Novartis)H-Index: 10
view all 6 authors...
Objectives: To describe the patient populations and infections being treated with daptomycin, as well as the efficacy and safety outcomes. Patients and methods: Data from the European Cubicin Outcomes Registry and Experience (EU-CORE ™ ), retrospectively collected at 118 institutions between January 2006 and August 2008, were analysed. Results: Daptomycin treatment was documented in 1127 patients with diverse infections, including complicated skin and soft tissue infections (33%), bacteraemia (2...
70 CitationsSource
Cited By6
Newest
#1Yoshitsugu Higashi (University of Toyama)H-Index: 5
#2Shigeki Nakamura (NIH: National Institutes of Health)H-Index: 20
Last. Yoshihiro Yamamoto (University of Toyama)H-Index: 31
view all 10 authors...
: A 53-year-old man was admitted to the hospital with a diagnosis of cellulitis and osteomyelitis. Twenty-four days after the initiation of daptomycin and sulbactam/ampicillin, he developed a fever and pulmonary infiltration. Bronchoalveolar lavage revealed a high number of eosinophils, while an intracutaneous test revealed positivity for daptomycin. The patient improved after discontinuing antimicrobial therapy. The plasma daptomycin minimum concentration (Cmin) was elevated (27.4 μg/mL), but p...
10 CitationsSource
#1Yonas Raru (Marshall University)H-Index: 3
#2Fuad Zeid (Marshall University)H-Index: 5
Last. Elizabeth Saunders (Marshall University)H-Index: 1
view all 4 authors...
Abstract We present two cases of daptomycin-induced eosinophilic pneumonia with characteristic chest x ray, CT scan and bronchoalveolar lavage (BAL) findings. It is not a commonly seen complication of Daptomycin but when it happens, it could cause a diagnostic and treatment dilemma. Patients could present acutely with hypoxic respiratory failure or a less dramatic chronic presentation is also possible. Our two patients presented with acute hypoxic respiratory failure and presentation resembles t...
1 CitationsSource
#1Jun Hirai (Aichi Medical University)H-Index: 10
#2Mao Hagihara (Aichi Medical University)H-Index: 13
Last. Jiro Fujita (University of the Ryukyus)H-Index: 33
view all 10 authors...
Abstract Here we report six cases of daptomycin (DAP)-induced eosinophilic pneumonia (DIEP) encountered at two medical centers and present a review of 43 DIEP patients from 26 studies to compare the clinical characteristics and radiographic findings of acute and chronic eosinophilic pneumonia (AEP; CEP). Four of the six patients did not exhibit respiratory symptoms, and one patient with only fever was misdiagnosed with DAP-induced fever. According to our literature review and the present finding...
8 CitationsSource
#1Priyasha UppalH-Index: 1
#2Kerry L. LaPlante (URI: University of Rhode Island)H-Index: 30
Last. Kristina E. Ward (URI: University of Rhode Island)H-Index: 11
view all 5 authors...
Eosinophilic pneumonia comprises a group of lung diseases in which eosinophils appear in increased numbers in the lungs and sometimes in the bloodstream. Several case reports link daptomycin use to this phenomenon. We performed a systematic literature review to identify cases of eosinophilic pneumonia associated with daptomycin use. Relevant studies were identified by searching Pubmed/Medline, EMBASE, Google Scholar, Cochrane Database of Systematic Reviews, and Clin-Alert from inception to May 2...
14 CitationsSource
#1Saira B. Chaudhry (RU: Rutgers University)H-Index: 3
Abstract The Side Effects of Drugs Annuals is a series of volumes in which the adverse effects of drugs and adverse reactions to them are surveyed. The series supplements the contents of Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions. This review of the January 2015 to December 2015 publications on miscellaneous antibacterial drugs covers aminoglycosides (amikacin, gentamicin and tobramycin), fluoroquinolones (ciprofloxacin, levofloxacin...
Source
Source